Endogena Investor Call 7th February 2024

Описание к видео Endogena Investor Call 7th February 2024

Endogena Therapeutics holds Investor Call and gives Retinitis Pigmentosa Clinical Trial Update: Listen to a testimonial from one of our principal investigators Dr. Victor Gonzalez
Zürich, Switzerland, February 7, 2024

Комментарии

Информация по комментариям в разработке